Takotsubo cardiomyopathy Afatinib-related in a non-small cell lung cancer patient: Case report

Endothelial Growth Factor Receptor (EGFR) mutations are frequently found among NSCLC patients. Second-generation Tyrosine Kinase Inhibitor (TKI) Afatinib is frequently used in this population of patients achieving better results than cytotoxic chemotherapy in terms of survival and progression. Afati...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	German E. Ramos, Christian Caglevic, Juan F. Bulnes, Sergio E. Panay, Mario I. Zapata, Andrés J. Daniele, Manuel E. Rodríguez
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2022-11-01
Serier:	Frontiers in Cardiovascular Medicine
Fag:	Takotsubo (stress) cardiomyopathy Afatinib EGFR mutation tyrosine kinase inhibition NSCLC
Online adgang:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.1060813/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!